Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Risk stratified usage of antibiotic-loaded bone cement for primary total knee arthroplasty: short term infection outcomes with a standardized cement protocol.

Qadir R, Sidhu S, Ochsner JL, Meyer MS, Chimento GF.

J Arthroplasty. 2014 Aug;29(8):1622-4. doi: 10.1016/j.arth.2014.02.032. Epub 2014 Mar 5.

PMID:
24703363
[PubMed - in process]
2.

Establishing a role for vancomycin powder application for prosthetic joint infection prevention-results of a wear simulation study.

Qadir R, Ochsner JL, Chimento GF, Meyer MS, Waddell B, Zavatsky JM.

J Arthroplasty. 2014 Jul;29(7):1449-56. doi: 10.1016/j.arth.2014.02.012. Epub 2014 Feb 12.

PMID:
24636904
[PubMed - in process]
3.

An evaluation of the use of topical tranexamic acid in total knee arthroplasty.

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

J Arthroplasty. 2013 Sep;28(8 Suppl):74-7. doi: 10.1016/j.arth.2013.06.037.

PMID:
24034510
[PubMed - indexed for MEDLINE]
4.

The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.

Bach MA, Rockwood K, Zetterberg C, Thamsborg G, H├ębert R, Devogelaer JP, Christiansen JS, Rizzoli R, Ochsner JL, Beisaw N, Gluck O, Yu L, Schwab T, Farrington J, Taylor AM, Ng J, Fuh V; MK 0677 Hip Fracture Study Group.

J Am Geriatr Soc. 2004 Apr;52(4):516-23.

PMID:
15066065
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk